In vitro activities of benzoxazinorifamycin krm 1648 against mycobacterium avium complex
Saito, H.; Fujii, K.; Tomioka, H.; Sato, K.; Hidaka, T.
Abstracts of the General Meeting of the American Society for Microbiology 92: 181
1992
ISSN/ISBN: 1060-2011 Accession: 031854379
Full Text Article emailed within 1 workday: $29.90
Related References
Inderlied, C.B.; Barbara-Burnham, L.; Wu, M.; Young, L.S.; Bermudez, L.E. 1994: Activities of the benzoxazinorifamycin KRM 1648 and ethambutol against Mycobacterium avium complex in vitro and in macrophages Antimicrobial Agents and ChemoTherapy 38(8): 1838-1843Tomioka, H.; Saito, H.; Fujii, K.; Sato, K.; Hidaka, T. 1993: In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method Antimicrobial Agents and ChemoTherapy 37(1): 67-70
Sato, K.; Akaki, T.; Tomioka, H. 1998: Antimicrobial activities of benzoxazinorifamycin KRM-1648, clarithromycin and levofloxacin against intracellular Mycobacterium avium complex phagocytosed by murine peritoneal macrophages Journal of Antimicrobial ChemoTherapy 41(1): 77-83
Mor, N.; Simon, B.; Heifets, L. 1996: Bacteriostatic and bactericidal activities of benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium in human macrophages Antimicrobial Agents and ChemoTherapy 40(6): 1482-1485
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 1996: Bacteriostatic and bactericidal activities of benzoxazinorifamycin Krm-1648 against Mycobacterium tuberculosis and Mycobacterium avium in human macrophages Antimicrobial Agents and Chemotherapy 40(6): 1482-1485
Gay, J.D.; Deyoung, D.R.; Roberts, G.D. 1984: In vitro activities of norfloxacin and ciprofloxacin against mycobacterium tuberculosis mycobacterium avium complex mycobacterium chelonei mycobacterium fortuitum and mycobacterium kansasii Antimicrobial Agents and Chemotherapy 26(1): 94-96
Sato, K.; Tomioka, H. 1999: Antimicrobial activities of benzoxazinorifamycin (KRM-1648) and clarithromycin against Mycobacterium avium-intracellulare complex within murine peritoneal macrophages, human macrophage-like cells and human alveolar epithelial cells Journal of Antimicrobial ChemoTherapy 43(3): 351-357
Saito, H.; Sato, K.; Tomioka, H. 1988: In vitro activities of rifabutine and rifampicin against various mycobacteria, especially Mycobacterium tuberculosis and Mycobacterium avium complex Kekkaku: 63(3): 167-172
Tomioka, H.; Saito, H.; Sato, K.; Yamane, T.; Yamashita, K.; Hosoe, K.; Fujii, K.; Hidaka, T. 1992: Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice Antimicrobial Agents and ChemoTherapy 36(2): 387-393
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 1997: Effects of benzoxazinorifamycin Krm-1648 on cytokine production at sites of Mycobacterium avium complex infection induced in mice Antimicrobial Agents and Chemotherapy 41(2): 357-362
Shimizu, T.; Tomioka, H.; Sato, K.; Akaki, T.; Ogasawara, K.; Kawahara, S. 1999: Therapeutic effects of benzoxazinorifamycin KRM-1648 administered alone or in combination with glycyrrhizin against Mycobacterium avium complex infection in mice Kekkaku: 74(8): 617-621
Tomioka, H.; Sato, K.; Shimizu, T.; Sano, C.; Akaki, T.; Saito, H.; Fujii, K.; Hidaka, T. 1997: Effects of benzoxazinorifamycin KRM-1648 on cytokine production at sites of Mycobacterium avium complex infection induced in mice Antimicrobial Agents and Chemotherapy 41(2): 357-362
Emori, M.; Tomioka, H.; Sato, K.; Saito, H. 1998: Evaluation of in vivo therapeutic efficacy of a new benzoxazinorifamycin, KRM-1648, in SCID mouse model for disseminated Mycobacterium avium complex infection International Journal of Antimicrobial Agents 10(1): 59-65
Tomioka, H.; Sato, K.; Akaki, T.; Kajitani, H.; Kawahara, S.; Sakatani, M. 1999: Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin , gatifloxacin , and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex Antimicrobial Agents and Chemotherapy 43(12): 3001-3004
Shoen, C.M.; Choromanska, O.; Reynolds, R.C.; Piper, J.R.; Johnson, C.A.; Cynamon, M.H. 1998: In vitro activities of several diaminomethylpyridopyrimidines against Mycobacterium avium complex Antimicrobial Agents and ChemoTherapy 42(12): 3315-3316